NCT03493698View on ClinicalTrials.gov

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

August 27, 2018

Study Completion Date

August 27, 2018

Conditions
Drug Interaction Potentiation
Interventions
DRUG

Midazolam

Midazolam

DRUG

Inarigivir

Inarigivir

Trial Locations (1)

Unknown

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

F-star Therapeutics, Inc.

INDUSTRY

NCT03493698 - A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects | Biotech Hunter | Biotech Hunter